Accéder au contenu
Merck

MAB8257F

Anti-Influenza A Antibody, nucleoprotein, clone A1, FITC-conjugated

clone A1, Chemicon®, from mouse

Se connecter pour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

100 μG

422.00 CHF

422.00 CHF


Vérifier la disponibilité des articles du panier

Demander une commande groupée

A propos de cet article

Code UNSPSC :
12352203
eCl@ss :
32160702
Nomenclature NACRES :
NA.41

Passer à

Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Source biologique

mouse

Niveau de qualité

Conjugué

FITC conjugate

Forme d'anticorps

purified antibody

Type de produit anticorps

primary antibodies

Clone

A1, monoclonal

Espèces réactives

human

Fabricant/nom de marque

Chemicon®

Technique(s)

immunofluorescence: suitable

Isotype

IgG2a

Conditions d'expédition

wet ice

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 4

Cet article
MAB8257BMAB8257MAB8251
species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

clone

A1, monoclonal

clone

A1, monoclonal

clone

A1, monoclonal

clone

A1, monoclonal, A3, monoclonal

antibody form

purified antibody

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

ascites fluid

conjugate

FITC conjugate

conjugate

biotin conjugate

conjugate

-

conjugate

-

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

Immunogène

Epitope: nucleoprotein
Influenza A

Application

Indirect Immunofluorescence

Optimal dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Influenza A Antibody, nucleoprotein, clone A1, FITC-conjugated is validated for use in IF for the detection of Influenza A.

Actions biochimiques/physiologiques

Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A. No cross reactivity seen to influenza B or other respiratory viruses.

Forme physique

Purified, FITC conjugated. Liquid in 0.02M phosphate buffer, 0.25M sodium chloride, pH 7.6 with 15 mg/mL BSA and 0.1% sodium azide

Notes préparatoires

Store at 2° to 8°C.

Autres remarques

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Informations légales

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Vous ne trouvez pas le bon produit ?  

Essayez notre Outil de sélection de produits.

Code de la classe de stockage

12 - Non Combustible Liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Katherine S Xue et al.
eLife, 5, e13974-e13974 (2016-03-16)
RNA viruses rapidly diversify into quasispecies of related genotypes. This genetic diversity has long been known to facilitate adaptation, but recent studies have suggested that cooperation between variants might also increase population fitness. Here, we demonstrate strong cooperation between two
Cheng-Chung Lee et al.
Scientific reports, 9(1), 4546-4546 (2019-03-16)
Influenza is a contagious acute respiratory disease caused by the influenza virus infection. Hemagglutinin (HA) is an important target in the therapeutic treatment and diagnostic detection of the influenza virus. Influenza A virus encompasses several different HA subtypes with different
David F Boyd et al.
Nature, 587(7834), 466-471 (2020-10-30)
Severe respiratory infections can result in acute respiratory distress syndrome (ARDS)1. There are no effective pharmacological therapies that have been shown to improve outcomes for patients with ARDS. Although the host inflammatory response limits spread of and eventually clears the
Jenna M Kastenschmidt et al.
Immunity, 56(8), 1910-1926 (2023-07-22)
Highly effective vaccines elicit specific, robust, and durable adaptive immune responses. To advance informed vaccine design, it is critical that we understand the cellular dynamics underlying responses to different antigen formats. Here, we sought to understand how antigen-specific B and
Surfactant protein A alters endosomal trafficking of influenza A virus in macrophages.
Yau, et al.
Frontiers in Immunology, 14, 919800-919800 (2023)

Questions

Reviews

No rating value

Active Filters

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique